BCM
AMAM

Bayesian Capital Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Bayesian Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,804
Closed -$225K – 1193
2023
Q4 		$225K Buy
+15,804
New +$225K 0.02% 574